Kentaro Jingushi Selected Research

Kentaro Jingushi Research Topics

22	Neoplasms (Cancer) 04/2024 - 01/2012
9	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 08/2015
4	Carcinoma (Carcinomatosis) 12/2022 - 04/2017
4	Urinary Bladder Neoplasms (Bladder Cancer) 05/2021 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 12/2008
2	Carcinogenesis 01/2023 - 04/2020
2	Disease Progression 12/2022 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Margins of Excision 10/2017

7	Biomarkers (Surrogate Marker)IBA 09/2023 - 04/2017
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2014
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2019
4	MicroRNAs (MicroRNA)IBA 04/2021 - 08/2015
3	Cell-Free Nucleic AcidsIBA 05/2019 - 04/2018
3	CateninsIBA 06/2014 - 01/2012
2	Bacterial DNAIBA 04/2024 - 09/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
2	human AZU1 proteinIBA 10/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2018
2	Celecoxib (Celebrex)FDA Link 01/2018 - 12/2008
1	16S Ribosomal RNAIBA 04/2024
1	PlatinumIBA 01/2023
1	pembrolizumabIBA 12/2022
1	Nucleic AcidsIBA 04/2021
1	locked nucleic acidIBA 04/2021
1	NucleosidesIBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	lardIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Organic Anion TransportersIBA 01/2021
1	Circulating Tumor DNAIBA 02/2019
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2018
1	CytokinesIBA 01/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018
1	Transfer RNA (tRNA)IBA 01/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2016
1	SurvivinIBA 01/2016
1	IntegrinsIBA 12/2014
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	Cyclin D1IBA 06/2014

3	Therapeutics 12/2022 - 02/2016
2	Oral Administration 01/2021 - 06/2014
2	Prostatectomy (Retropubic Prostatectomy) 01/2018 - 10/2017
1	Immunotherapy 12/2022